GlassScriptPhysician profile
Peter W Lundberg
NPI 1619267952
$4,952.66
in general payments reported to CMS, 2019-2025
18 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,963 · 2020: $354 · 2021: $154 · 2022: $499 · 2023: $1,021 · 2024: $339 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,981.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,980.87 | 2019-2023 | Da Vinci Surgical System |
| Abbvie INC. | $698.56 | 2023-2025 | |
| Allergan, INC. | $579.99 | 2019-2022 | |
| Ethicon US, LLC | $439.91 | 2019-2025 | Echelon Flex, Linx Reflux Management System, Harmonic |
| Medtronic, INC. | $430.17 | 2022-2025 | Endo Gia Ultra, Signia |
| Laborie Medical Technologies Corp. | $179.73 | 2025 | |
| Baxter Healthcare | $124.75 | 2019-2020 | |
| Davol INC. | $123.22 | 2020 | |
| W. L. Gore & Associates, INC. | $118.26 | 2019-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Covidien LP | $66.00 | 2019-2020 | |
| Becton, Dickinson and Company | $65.92 | 2023 | Phasix Mesh |
| Ambu INC. | $23.64 | 2023 | |
| Standard Bariatrics, INC. | $23.14 | 2022 | |
| Acera Surgical, INC. | $23.04 | 2025 | Restrata Wound Matrix |
| Karl Storz Endoscopy-America | $22.58 | 2024 | Image1 S Connect |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $20.20 | 2022 | |
| Convatec INC. | $19.59 | 2019 | |
| Tela Bio, INC. | $13.09 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Lundberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.